Tassilo L A Wachsmann

7PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 15, 2022
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.

Laura T Morton, Tassilo L A Wachsmann, Miranda H Meeuwsen

|Feb 07, 2022
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.

Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst

|Nov 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

Dyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers

Pageof 2